SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: vestor who wrote (1196)5/19/1999 12:52:00 PM
From: Thure Meyer  Respond to of 1837
 
Vestor,

This stock is getting into that rarified air where the short covering is over and the only resistance will be more shorting and the occasional profit taking. You would have to be very brave to short the stock at this time and barring some negative news, what will stop this climb?. When is the next 10-Q? We may see some preliminary revenue figures which will be very telling.

Thure



To: vestor who wrote (1196)5/19/1999 1:02:00 PM
From: CASINO1  Read Replies (1) | Respond to of 1837
 
Anyone know what market share DRMD expects for Cenestin? Some one on yahoo ran some numbers an said a 10% share of the Premarin market works out to a $6 per share gain to DRMD. Can anyone verify this. Just wondering.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News